Transcatheter tricuspid valve replacement with LuX-valve device: Overview of key echocardiographic considerations.
Xin WeiXi LiYujia LiangFei ChenZhengang ZhaoYuan FengMao ChenPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
Tricuspid regurgitation is a common valve disease with high incidence and poor prognosis. For elderly patients and those with a history of open heart surgery, second thoracotomy and valve replacement carry a high risk. Transcatheter tricuspid valve replacement (TTVR) has become an alternative treatment for patients with high surgical risk. LuX-Valve is a novel self-expandable valve that does not rely on radial force to anchor the valve annulus. The preliminary results have been satisfactory, and this technology is gradually being adopted in China and around the world. Successful implementation of this technique depends on echocardiographic preoperative screening, intraoperative guidance, and postoperative follow-up. The purpose of this article is to provide a state-of-the-art review of the key points and technical considerations for preoperative screening, intraoperative guidance, and postoperative follow-up for TTVR.
Keyphrases
- aortic valve
- mitral valve
- aortic stenosis
- transcatheter aortic valve replacement
- aortic valve replacement
- transcatheter aortic valve implantation
- ejection fraction
- patients undergoing
- poor prognosis
- left ventricular
- left atrial
- long non coding rna
- primary care
- coronary artery disease
- pulmonary hypertension
- atrial fibrillation
- combination therapy
- ultrasound guided
- surgical site infection
- percutaneous coronary intervention